Back to today’s briefing

Story perspectives

£523K Brineura Debate: Worth of Young Lives at Stake

4/17/2025

32 2

Summary

Story summary

On April 3rd, a heated debate unfolded among health experts in England over funding Brineura, a staggering £523,000 enzyme therapy for 33 children battling Batten disease. While the drug offers hope by slowing progression, it ignites ethical dilemmas about the worth of young lives, as untreated children rarely live beyond 12, losing vital skills along the way.

1 of 1

Story summary

On April 3rd, a heated debate unfolded among health experts in England over funding Brineura, a staggering £523,000 enzyme therapy for 33 children battling Batten disease. While the drug offers hope by slowing progression, it ignites ethical dilemmas about the worth of young lives, as untreated children rarely live beyond 12, losing vital skills along the way.